ovalbumin and Central-Nervous-System-Diseases

ovalbumin has been researched along with Central-Nervous-System-Diseases* in 2 studies

Other Studies

2 other study(ies) available for ovalbumin and Central-Nervous-System-Diseases

ArticleYear
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
    Nature, 2009, Nov-05, Volume: 462, Issue:7269

    The tissues of the central nervous system are effectively shielded from the blood circulation by specialized vessels that are impermeable not only to cells, but also to most macromolecules circulating in the blood. Despite this seemingly absolute seclusion, central nervous system tissues are subject to immune surveillance and are vulnerable to autoimmune attacks. Using intravital two-photon imaging in a Lewis rat model of experimental autoimmune encephalomyelitis, here we present in real-time the interactive processes between effector T cells and cerebral structures from their first arrival to manifest autoimmune disease. We observed that incoming effector T cells successively scanned three planes. The T cells got arrested to leptomeningeal vessels and immediately monitored the luminal surface, crawling preferentially against the blood flow. After diapedesis, the cells continued their scan on the abluminal vascular surface and the underlying leptomeningeal (pial) membrane. There, the T cells encountered phagocytes that effectively present antigens, foreign as well as myelin proteins. These contacts stimulated the effector T cells to produce pro-inflammatory mediators, and provided a trigger to tissue invasion and the formation of inflammatory infiltrations.

    Topics: Animals; Antigen-Presenting Cells; Antigens; Cell Movement; Cells, Cultured; Central Nervous System Diseases; Encephalomyelitis, Autoimmune, Experimental; Meninges; Mice; Ovalbumin; Phagocytes; Rats; Rats, Inbred Lew; T-Lymphocytes

2009
Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders.
    Biomaterials, 1999, Volume: 20, Issue:4

    Nerve growth factor (NGF) may enhance axonal regeneration following injury to the central nervous system (CNS), such as after spinal cord injury. The release profile of NGF, co-encapsulated with ovalbumin, was tailored from biodegradable polymeric microspheres using both polymer degradation and protein loading. Biodegradable polymeric microspheres were prepared from PLGA 50/50, PLGA 85/15, PCL and a blend of PCL/PLGA 50/50 (1:1, w/w), where the latter was used to further tailor the degradation rate. The amount of protein loaded in the microspheres was varied, with PCL encapsulating the greatest amount of protein and PLGA 50/50 encapsulating the least. A two-phase release profile was observed for all polymers where the first phase resulted from release of surface proteins and the second phase resulted predominantly from polymer degradation. Polymer degradation influenced the release profile most notably from PLGA 50/50 and PLGA 85/15 microspheres. The amount and bioactivity of released NGF was followed over a 91 d period using a NGF-ELISA and PC12 cells, respectively. NGF was found to be bioactive for 91 d, which is longer than previously reported.

    Topics: Animals; Biodegradation, Environmental; Cell Differentiation; Central Nervous System Diseases; Drug Carriers; Lactic Acid; Microspheres; Nerve Growth Factors; Neurons; Ovalbumin; PC12 Cells; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats

1999